Benefit of Provenge for Progressive Metastatic Prostate Cancer Challenged

A recent report questioned whether Provenge is really beneficial for men with progressive, asymmptomatic or minimally symptomatic metastatic disease. This was not based on any new studies, however, and the FDA and other experts have pointed out the flaws in this article as discussed in the video. The bottom line for patients is also reviewed.

Tags: , ,

Category: In The News

Leave a Reply

You must be logged in to post a comment.